t84.1 (InVivo BioTech Services)
Structured Review

T84.1, supplied by InVivo BioTech Services, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t84%2E1/pmc04951702-241-11-12?v=InVivo+BioTech+Services
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "CEACAM1 mediates B cell aggregation in central nervous system autoimmunity"
Article Title: CEACAM1 mediates B cell aggregation in central nervous system autoimmunity
Journal: Scientific Reports
doi: 10.1038/srep29847
Figure Legend Snippet: B cell aggregation was induced by 16 h of incubation with anti-CD19 ( A , compare untreated to anti-CD19-treated cells). ( B – D ) Inhibition of CD19-induced B cell aggregation by the anti-CEACAM1 antibody clones C5-1X (150 μg/ml) ( B ), 4D1/C2 (150 μg/ml) ( C ) and T84.1 (150, 250 vs . 400 μg/ml) ( D ). B cells were isolated from n = 3 ( B,C ) or n = 9 ( D ) healthy donors, respectively. ( E ) Induction of B cell aggreation by anti-CD19 antibody and its inhibition by T84.1 in age- and gender-matched MS patients ( n = 4) and healthy controls ( n = 4).
Techniques Used: Incubation, Inhibition, Clone Assay, Isolation